We believe collective action is the most untapped source of progress on societal issues. We believe in mutual collaboration and community, in joining forces and in building synergies to deliver on the challenges we face.Find out more
We identify the right people and organisations, bring them together, provide overall strategic direction and co-ordination. In parallel we manage fundraising, communications and technical development.Become our partner
The Synergist gathers diverse social and economic agendas together under one shared purpose.
The Synergist provides the right structure, expertise and momentum for shared value initiatives to take seed and flourish.
The Synergist brings the right people, organisations and institutions around the table.
Break Dengue aims to connect different initiatives around the world that are addressing the issue of dengue so that together they can have a bigger impact.Find out more
The Motherhood Collective Impact Programme aims to empower all motherhood stakeholders, from grassroots groups to advocacy and large organisations, to accelerate impact and avoid duplication.Find out more
PFMD aims to transform the way in which we understand, engage, and partner with patients globally in the design and development of research and medicines by focusing on unmet patient needs.Find out more
Share4Rare is a collective online platform with the ambition to make a difference for rare disease patients and their families.Find out more
PARADIGM aims to provide a unique framework that enables structured, effective, meaningful, ethical, innovative and sustainable patient engagement.Find out more
IMI Conception is a five-year project that aims to tackle the fragmented landscape around medication in pregnancy and breastfeeding.Find out more
Synchros is a three-year project that aims to map the cohort landscape in Europe and large international initiatives, identify best methods for integrating cohort data followed by the solutions to address challenges arising in integrating data across patient, clinical trial and population cohorts.Find out more